A new approach to an AIDS vaccine: Creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem

Medical Hypotheses

Volumn 64, Issue 2, 2005, Pages 261-263

  Jeffrey Fessel, W ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTIDINE DEAMINASE; CYTIDINE DEAMINASE APOBEC3G; DEFENSIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG; VIF PROTEIN; VIF VACCINE; VIRUS DNA;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; DNA STRAND; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION;

AIDS VACCINES; GENE PRODUCTS, VIF; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; NUCLEOSIDE DEAMINASES; PROTEINS; REPRESSOR PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; SUID HERPESVIRUS 1; SUIDAE;

EID: 11144326376     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.07.015     Document Type: Article

References (22)

1. R.C. Desrosiers Prospects for an AIDS vaccine Nat Med 10 2004 221 223
2. D. Lecossier, F. Bouchonnet, F. Clavel, and A.J. Hance Hypermutation of HIV-1 DNA in the absence of the vif protein Science 300 2003 1112
3. B. Mangeat, P. Turelli, G. Caron, M. Freidli, L. Perrin, and D. Trono Broad antiretroviral defense by human apobec3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
4. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-.F. Yu Induction of apobec3G ubiquitination and degradation by an HIV-1 vif-cul5-SCF complex Science 302 2003 1056 1060
5. Mehle A, Strack B, Ancuta P, Gabuzda D. HIV-1 Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteosome pathway. In: 11th conference on retroviruses and opportunistic infections, February 8-11, San Francisco, CA; 2004 [Abstract 62]
6. Hassaine G, Agostini I, Candotti D, Bessou G, Caballero M, Agut H, Autran B, Barthalay Y, the French ALT Study Group, Vigne R. Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Virology 2000;276:169-180
7. L. Alexander, E. Weiskopf, T.C. Greenough, N.C. Gaddis, M.R. Auerbach, M.H. Malim, S.J. O'Brien, B.D. Walker, J.L. Sullivan, and R.C. Desrosiers Unususal polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection J Virol 74 2000 4361 4376
8. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral vif protein Nature 418 2002 646 650
9. S. O'Shea, T. Rostron, A.S. Hamblin, S.J. Palmer, and J.E. Banatvala Quantitation of HIV: correlation with clinical, virological, and immunological status J Med Virol 35 1991 65 69
10. S. Schwander, R.W. Braun, J.E. Kuhn, F.T. Hufert, P. Kern, M. Dietrich, and U. Wieland Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infection J Med Virol 36 1992 142 146
11. Zverev SIa, A.F. Bobkov, and M.M. Garaev The use of vif gene expression product of HIV-1 in bacteria for detecting specific antibodies in the sera of infected persons Vop Virusol 37 1992 16 19
12. C. O'Neil, D. Lee, G. Clewley, M.A. Johnson, and V.C. Emery Prevalence of anti-vif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed vif protein J Med Virol 51 1998 139 144
13. U. Wieland, H. Kratschmann, R. Kehm, J.E. Kuhn, H. Naher, M.D. Kramer, and R.W. Braun Antigenic domains of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies AIDS Res Hum Retroviruses 7 1991 861 867
14. V. Ayyavoo, T. Nagashunmugam, J. Boyer, S. Mahalingam, L.S. Fernandes, P. Le, J. Lin, C. Nguyen, M. Chattargoon, J.J. Goedert, H. Friedman, and D.B. Weiner Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes AIDS 11 1997 1433 1444
15. J. Goncalves, F. Silva, A. Freitas-Vieira, M. Santa-Marta, R. Malho, R. Yang, D. Gabuzda, and C. Barbas III Functional neutralization of HIV-1 vif protein by intracellular immunization inhibits reverse transcription and viral replication J Biol Chem 277 2002 32036 32045
16. H.W. Favoreel, H.J. Nauwynck, P. Van Oostveldt, and M.B. Pensaert Role of anti-gB and -gD antibodies in antibody-induced endocytosis of viral and cellular cell surface glycoproteins expressed on pseudorabies virus-infected monocytes Virology 267 2000 151 158
17. S.X. Deng, E. Hanson, and I. Sanz In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies Int Immunol 12 2000 415 423
18. B.T. Edelson, and E.R. Unanue Intracellular antibody neutralizes Listeria growth Immunity 14 2001 503 512
19. G.M. Winslow, E. Yager, K. Shilo, E. Volk, A. Reilly, and F.K. Chu Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection Infect Immun 68 2000 2187 2195
20. A. Casadevall Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle Infect Immun 71 2003 4225 4228
21. T.R. Reddy, G. Kraus, M. Suhasini, M.C. Leavitt, and F. Wong-Staal Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene J Virol 69 1995 5167 5170
22. G. Vogt, R. leGrand, B. Vaslin, F. Boussin, M.H. Auboyer, Y. Riviere, P. Putkonen, P. Sonigo, M.P. Kieny, and M. Girard Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins Vaccine 13 1995 202 208